PATENT CLAIM ANALYSIS

Application Number: 16016369
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2019-01
Patent Classification: ["536", "029200"]

Abstract:
Provided are compounds of Formula I, as well as pharmaceutical compositions containing compounds of Formula I and methods for treating Orthomyxoviridae virus infections by administering these compounds. The compounds, compositions, and methods provided are particularly useful for the treatment of Human Influenza virus infections.

Claim (Index 15):
The compound of  claim 13 , wherein R 4  is \u2550O or NH 2 .

Metadata:
- Claim Count in Document: 50.0
- Percentile: 94.0
- Lexical Diversity: 1.58065
- Patent Class: 536.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13793557', '15267433', '14534715', '13050820', '12885917']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6218301845470094
- 35 USC 102 Novelty (BERT): 0.5579789145166121
- Combined Prediction Score: 0.6154450575439697
- Mean Citation Score: 326.92198599999995
- Max Citation Score: 459.50238
- Similarity Product: 340.73151375888705

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test